Aspergillus pneumonia in renal transplant recipients.
- Author:
Xiao-dong ZHANG
1
;
Xiao-peng HU
;
Hang YIN
;
Wei WANG
;
Xin ZHANG
;
Lin-Lin MA
;
Yong WANG
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aspergillosis; diagnosis; drug therapy; etiology; Cohort Studies; Female; Humans; Kidney Transplantation; adverse effects; Lung Diseases, Fungal; diagnosis; drug therapy; etiology; Male; Middle Aged; Pneumonia; diagnosis; drug therapy; etiology; Retrospective Studies; Tomography, X-Ray Computed
- From: Chinese Medical Journal 2008;121(9):791-794
- CountryChina
- Language:English
-
Abstract:
BACKGROUNDFilamentous fungal infections are associated with a high morbidity and mortality in solid organ transplants. The present study aimed to investigate the aspergillus pneumonia in renal transplant recipients, and its diagnosis as well as treatment.
METHODSApproximately 2000 cases of renal transplants were retrospectively studied and we focused on cases hospitalized during August 1, 2005 and February 1, 2007, as the study period. The clinical database and electronic records were analyzed. Recently published literature was reviewed.
RESULTSThere was more diabetes and hypertension in the infected group than in the non-infected group (86% vs 62% and 57% vs 39%, respectively). Eighty-six percent of recipients from the infected group had delayed graft function. Seven cases with aspergillus pneumonia were identified based on either fungal culture or radiology. Of the 7 cases, 4 died in a few days after diagnosis. Liposomal amphotericin B was used as a first-line therapy.
CONCLUSIONSIncidences of fungal infection are increasing among renal transplant recipients. Early diagnosis and treatment are critical steps in curing aspergillosis.